2024-04-29 08:48Financial Performance - The company's operating revenue for Q1 2024 was CNY 645,995,271.22, representing a year-on-year increase of 5.68%[6] - The net profit attributable to shareholders for Q1 2024 was CNY 97,541,532.98, reflecting a growth of 20.16% compared to the same period last year[6] - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 95,217,851.02, which is an increase of 33.05% year-on-year[6] - The basic earnings per share for Q1 2024 was CNY 0.58, up by 23.40% from CNY 0.47 in Q1 2023[18] - Net profit for the current period reached 92,488,777.12, an increase from 84,951,683.69 in the previous period, representing a growth of approximately 6.4%[41] - Total revenue from operating profit was 114,427,839.61, slightly up from 111,265,909.95, indicating a growth of about 1.9%[41] - The company's earnings per share attributable to shareholders increased to 97,541,532.98 from 81,177,581.15, representing a growth of about 20.2%[41] Assets and Liabilities - The total assets at the end of Q1 2024 amounted to CNY 7,192,952,822.94, a 1.23% increase from the end of the previous year[26] - As of March 31, 2024, total current assets amounted to approximately RMB 3.75 billion, slightly down from RMB 3.75 billion at the end of 2023[32] - The company’s total assets reached approximately RMB 7.19 billion, up from RMB 7.11 billion at the end of 2023[32] - The company's total liabilities amounted to 1,070,720,682.01, a decrease from 1,088,203,977.97, reflecting a reduction of approximately 1.6%[45] - The total equity attributable to shareholders increased to 5,755,069,480.72 from 5,650,064,203.23, marking an increase of about 1.9%[45] Cash Flow - The net cash flow from operating activities for Q1 2024 was CNY 75,969,702.64, a decrease of 4.96% compared to the previous year[6] - The company reported a net cash inflow from investment activities of CNY 159,290,447.77 for Q1 2024, compared to CNY 156,184,009.96 in the same period last year[19] - The company reported a net cash inflow from financing activities of approximately RMB 42.14 million, a significant improvement from a net outflow of RMB 20.94 million in the previous period[38] Research and Development - The total R&D expenditure for Q1 2024 was CNY 64,900,123.30, which accounted for 10.05% of the operating revenue, an increase of 1.28 percentage points year-on-year[26] Shareholder Information - The top ten shareholders hold a combined 88.68% of the shares, with the largest shareholder owning 28.17%[28] Government Subsidies - The company received government subsidies amounting to CNY 3,820,341.64 during the reporting period[26] - Government subsidies received during the reporting period decreased significantly compared to the same period last year, leading to a 75.83% decline in non-recurring net gains[28] Inventory and Cash Management - Cash and cash equivalents at the end of the reporting period were RMB 846.19 million, an increase from RMB 772.22 million at the end of the previous year[38] - Inventory as of March 31, 2024, was approximately RMB 533.64 million, showing a slight increase from RMB 526.17 million at the end of 2023[32] Strategic Focus - The company continues to focus on high-margin hyaluronic acid products, contributing to overall gross profit growth[28] - The company is actively exploring new product development and market expansion strategies to enhance its competitive position[28] Other Financial Metrics - The weighted average return on equity for Q1 2024 was 1.72%, an increase of 0.24 percentage points year-on-year[26] - Interest income decreased to 17,894,671.58 from 19,194,643.89, a decline of approximately 6.8%[41] - Other comprehensive income after tax showed a significant drop to -21,216,593.79 from 3,063,929.44, indicating a negative shift[41] - The company reported a decrease in credit impairment losses to -476,413.55 from -2,445,931.34, showing an improvement in credit quality[41] - The company’s capital reserve decreased to 2,903,610,489.65 from 2,980,937,753.79, a decline of approximately 2.6%[45]